Medtronic ’s Redemption Arc for RDN Continues at EuroPCR
Redemption of Medtronic’s renal denervation program to treat hypertension is seemingly on the horizon. The Dublin-based company reported results from an investigator-led study and a registry that demonstrate long-term results of RDN’s impact on uncontrolled hypertension. These results were presented during a Late-Breaking Clinical Trial session at EuroPCR in Paris. In the investigator -led study data indicated RDN with the Medtronic Symplicity system was associated with reduced occurrence of subclinical Atrial Fibrillation (AFib) in a small subset of high-risk patients with hypertensive ...
Source: MDDI - May 22, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

Algorithm steers catheters to the right spot to treat atrial fibrillation
(Florida Atlantic University) Some patients with atrial fibrillation or A-Fib need an ablation, which requires a catheter and an advanced 3D map of the heart. Researchers have developed the first algorithm that guides catheter movements and accurately detects A-Fib targets without 3D maps of the heart. In human simulations, this technique stops the catheter at the right target and identifies the source type with a 95.25% success rate and a 99 percent detection rate of scar tissue, regardless of scar size. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 21, 2019 Category: Biology Source Type: news

AF: Highly Prevalent Yet Undertreated in Patients With NASH AF: Highly Prevalent Yet Undertreated in Patients With NASH
This study found that the prevalence of atrial fibrillation in patients with NASH is twice that of the general population. Are these patients receiving appropriate anticoagulation therapy?Liver International (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 20, 2019 Category: Intensive Care Tags: Gastroenterology Journal Article Source Type: news

Anticoagulation After Catheter Ablation of AF: Unnecessary? Anticoagulation After Catheter Ablation of AF: Unnecessary?
Do the risks of oral anticoagulation after cathether ablation for atrial fibrillation outweigh the benefits?Journal of Cardiovascular Electrophysiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Only 1 in 5 With High-Risk AF Leave ED on Anticoagulant Only 1 in 5 With High-Risk AF Leave ED on Anticoagulant
A study of nearly 450 people with atrial fibrillation (AF) treated in the emergency department suggests that anticoagulants may be'vastly underutilized'for the prevention of stroke.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 17, 2019 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Pradaxa Fails to Prevent Recurrence After Cryptogenic Stroke Pradaxa Fails to Prevent Recurrence After Cryptogenic Stroke
Dabigatran, sold under the brand name Pradaxa by Boehringer Ingelheim to prevent stroke in people with atrial fibrillation, is no more effective than aspirin for preventing a subsequent stroke in patients who have experienced a cryptogenic stroke.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 16, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

We Still Need a Sham-Controlled Trial for AF Ablation We Still Need a Sham-Controlled Trial for AF Ablation
Catheter ablation for atrial fibrillation has yet to be put to the ultimate test of a sham-controlled trial. John Mandrola, MD, makes the case for doing one now.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 10, 2019 Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news

HRS: Ear Clip Uses Neurostimulation to Effectively Reduce AFib Burden
A trial evaluating Parasym’s neurostimulation technology shows the ear-clip like device can help reduce the atrial fibrillation burden. The results were presented at the Heart Rhythm Society’s 40th Annual Scientific Sessions held in San Francisco. The TREAT AF trial is a sham-controlled, double-blind, randomized clinical trial designed to examine the effect of low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve at the tragus (LLTS) on AFib burden over a six-month period. LLTS was delivered using an ear clip attached to either tragus (active; n=26) o...
Source: MDDI - May 9, 2019 Category: Medical Devices Authors: MDDI Staff Tags: Cardiovascular Source Type: news

' Zap' Ear Clip May Ease A-Fib
THURSDAY, May 9, 2019 -- Imagine if all it took to treat the heart condition atrial fibrillation was clipping a small device to your ear for an hour a day? That futuristic scenario could soon be a reality, according to a new study. In a small, early... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 9, 2019 Category: General Medicine Source Type: news

Philips Announces Collaboration with Medtronic to Further Advance the Image-Guided Treatment of Atrial Fibrillation
Royal Philips (NYSE: PHG, AEX: PHIA) today announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder. Through the agreement, Medtronic will facilitate sales of products on behalf of Philips to provide an innovative, integrated image guidance solution for cryoablation procedures. (Source: eHealth News EU)
Source: eHealth News EU - May 9, 2019 Category: Information Technology Tags: Featured Philips Business and Industry Source Type: news

Preablation Bariatric Surgery Linked to Reduced A-Fib Recurrence
WEDNESDAY, May 8, 2019 -- For morbidly obese patients with atrial fibrillation (AF), those undergoing preablation bariatric surgery have reduced rates of recurrence, according to a study presented at the annual meeting of the Heart Rhythm Society,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2019 Category: Pharmaceuticals Source Type: news

Weight-Loss Surgery Boosts Success of Procedure to Fix A-Fib
WEDNESDAY, May 8, 2019 -- Profoundly obese people are prone to an irregular heartbeat known as atrial fibrillation, but new research suggests that weight-loss surgery can improve the odds that a procedure to restore a normal heart rhythm will... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 8, 2019 Category: General Medicine Source Type: news

Patients with atrial fibrillation to be targeted in stroke reduction programme
Programme will identify and treat patients with atrial fibrillation not receiving adequate preventive care Related items fromOnMedica The new GP contract: transforming primary care, transforming CVD prevention Fund specialist dementia training to improve care and save money Brexit could result in thousands of extra CVD deaths Risk of CV event highest straight after partner death Millions miss out on vital diabetes health checks (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 7, 2019 Category: UK Health Source Type: news

Deadly outcome after ingestion of squirting cucumber - Patabendige SHM, Svendsen JB, Kampmann JD.
In this case report, an 83-year-old woman with dementia was admitted to hospital with vomiting and diarrhoea. Her medical history included dementia, atrial fibrillation and seizures. She had accidentally ingested a kind of "fruit", which was used as part o... (Source: SafetyLit)
Source: SafetyLit - May 3, 2019 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Atrial fibrillation patients often overestimate risk of stroke, bleeding
(Reuters Health) - Patients with the irregular heart rhythm atrial fibrillation may overestimate both their risk of having a stroke and their risk of bleeding as a side effect of medication prescribed to prevent strokes, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - April 30, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

29.04.19: Not intended for U.S. and UK Media
Study reaffirms safety and efficacy profile of Xarelto™ for the prevention of stroke in patients with atrial fibrillationFirst results from RELOADED, an observational study in the EU, indicate that non-vitamin-K oral anticoagulants (NOACs) like Xarelto provide a benefit in renal preservation over time when compared to the vitamin-K antagonist (VKA) phenprocoumon / The data from the comparative effectiveness study in Germany confirm an improved safety outcome and comparable effectiveness for Xarelto compared with phenprocoumon in patients with non-valvular atrial fibrillation (NVAF), including those with renal insuffi...
Source: Bayer IR Newsfeed: Events - April 29, 2019 Category: Pharmaceuticals Source Type: news

AliveCor ’s New Indications Help Consumers Understand Their Hearts
AliveCor is giving consumers a chance to understand their heart (beats) a whole better through a pair of new indications. The Mountain View, CA-based company said its KardiaMobile ECG is now cleared for the detection of BradyCardia and TachyCardia. Previously, AliveCor had a nod from FDA for KardiaMobile to detect Atrial Fibrillation (AFib) and Normal Sinus Rhythm. The Mountain View, CA-based company said the new indications make it the only consumer-cleared device with the ability to detect the three most common heart arrhythmias. "No other consumer ECG device in the world, can tell you more about your heart than Kar...
Source: MDDI - April 24, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Association Between NAFLD and Risk of AF in Adults Association Between NAFLD and Risk of AF in Adults
This study aimed to provide a quantitative estimate of the magnitude of the association between NAFLD and risk of atrial fibrillation in the middle-aged and elderly.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 22, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

10 Biggest Myths About Sleeping, According To Researchers
(CNN) — Hey, sleepyheads. What you believe about sleep may be nothing but a pipe dream. Many of us have notions about sleep that have little basis in fact and may even be harmful to our health, according to researchers at NYU Langone Health’s School of Medicine, who conducted a study published Tuesday in the journal Sleep Health. “There’s such a link between good sleep and our waking success,” said lead study investigator Rebecca Robbins, a postdoctoral research fellow in the Department of Population Health at NYU Langone Health. “And yet we often find ourselves debunking myths, whether ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 16, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch News CNN Sleep Source Type: news

ASK THE GP: Will I be on blood thinners for life? 
I developed anaemia after being prescribed the blood thinner apixaban for atrial fibrillation and my stools turned black, says Carol Crosbie, from Huntingdon, Cambridgeshire. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2019 Category: Consumer Health News Source Type: news

Patch Offers a New Approach for Treating Iron Deficiency
Patch-like wearables are becoming increasingly popular in medtech. The latest device to employ such a design and make medtech headlines is transdermal patch being developed by Fe3 Medical. San Antonio, TX-based Fe3 said its biphasic iontophoretic transdermal technology is for the treatment of iron deficiency anemia. The firm announced results from its first human study of the patch-like device. The human study focused on the safety and tolerability of Fe3's iontophoretic transdermal technology designed to bypass ionic resistance build up in the skin. The human study follows a series of successful preclinical studies demons...
Source: MDDI - April 15, 2019 Category: Medical Devices Authors: Omar Ford Tags: Adhesives Source Type: news

Atrial Fibrillation Ablation in Heart Failure Atrial Fibrillation Ablation in Heart Failure
This review summarizes current evidence for catheter ablation in patients with atrial fibrillation and concomitant heart failure, highlighting emerging technologies and future directions.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Conformal Medical launches LAA seal study
Conformal Medical said yesterday that it launched an investigational device exemption trial for a device designed to seal off the heart’s left atrial appendage to help prevent stroke in atrial fibrillation patients. Nashua, N.H.-based Conformal’s device is designed to adapt to the each patient’s individual physiology, to be easier to implant with less imaging and without general anesthesia. The 45-patient, single-arm study is designed to evaluate the device’s performance, with an estimated primary completion date of April 2020 and a final completion date of June 2025, according to ClinicalTrials.gov...
Source: Mass Device - April 10, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Implants Clinical Trials Featured Conformal Medical Source Type: news

Morgan Stanley: Apple ’ s mHealth play could triple entire mobile market
Though Apple (NSDQ:AAPL) has only begun to step into the healthcare market, a group of Morgan Stanley analysts estimate the company’s opportunity in the U.S. healthcare market to be three times larger than the global smartphone market, according to a Bloomberg report. The analysts estimated that Apple’s healthcare market opportunities could be worth between $15 billion up to a massive $313 billion by 2027, according to the report. The Cupertino, Calif.-based tech giant’s massive ecosystem built around the iPad and iPhone, other iOS devices and its App Store could allow Apple to disrupt “various...
Source: Mass Device - April 9, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured mHealth (Mobile Health) Wall Street Beat Apple Source Type: news

Integrated Care to Reduce Atrial Fibrillation Burden Integrated Care to Reduce Atrial Fibrillation Burden
Should all overweight patients with symptomatic AF be referred to weight management programs?Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Afib 2019 Guidelines Update: 5 Questions for Primary Care
Evidence-based revisions to the AHA/ACC/HRS guidelines will affect management of your patients with atrial fibrillation. Do you know how? Find out with a quick quiz. (Source: ConsultantLive)
Source: ConsultantLive - April 3, 2019 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Source Type: news

ELIMINATE-AF: Edoxaban Viable Alternative to VKA in AF Ablation ELIMINATE-AF: Edoxaban Viable Alternative to VKA in AF Ablation
Oral anticoagulant edoxaban was as efficacious and safe as a VKA for use in catheter ablation of atrial fibrillation, an exploratory trial shows. The major composite outcome and bleeding were similar.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 3, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Alcohol, caffeine are common triggers of irregular heart rhythm
(Reuters Health) - The most common triggers of atrial fibrillation - an irregular heart rhythm that's a leading cause of stroke - are avoidable behaviors like drinking alcohol or coffee, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 29, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

CardioFocus is Becoming a Force to Be Reckoned with in AFib Market
CardioFocus is quickly positioning itself to be a dominant player in the growing atrial fibrillation (AFib) treatment market. Regulatory approvals coupled with triple-digit-growth are helping to shape the Marlborough, MA-based into a force to be reckoned with in a market filled with intense competition. Last week, CardioFocus further strengthened its presence in the market by receiving CE mark for the HeartLight X3 System. The device is the latest generation of the company’s AFib treatment technology and could help the firm continue to thrive Europe, a market set to reach between 14 million and 17 million...
Source: MDDI - March 29, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Mar 29 2019 This Week in Cardiology Mar 29 2019 This Week in Cardiology
Catheter ablation for atrial fibrillation, eggs, booze, and anti-thrombotic agents for double vs triple therapy in patients with ACS and AF are discussed in this week ’ s podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 29, 2019 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Apple Heart Study Raises Myriad Questions Apple Heart Study Raises Myriad Questions
The Apple Heart Study produced an 84% positive predictive value for atrial fibrillation, but it raises important questions about wearable consumer health devices and how medicine will deal with them.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 27, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Taking the Pulse of the Apple Heart Study Taking the Pulse of the Apple Heart Study
What did we really learn from the study using a smart watch and phone app to identify atrial fibrillation? New ways to conduct research, but not much to advance practice, argues John Mandrola, MD.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 27, 2019 Category: Cardiology Tags: Cardiology Expert Column Source Type: news

Giving Up Alcoholic Drinks in AF May Cut AF Burden, Recurrence Giving Up Alcoholic Drinks in AF May Cut AF Burden, Recurrence
Moderate drinkers in sinus rhythm after atrial fibrillation had fewer recurrences after stopping or at least cutting sharply back on their alcohol intake in a groundbreaking randomized trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 26, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Smart wristband developed by Lithuanian researchers can alert about dangerous health conditions
(Kaunas University of Technology) Although smart wristbands are popular fashion gadgets for monitoring heart rate and physical activity, they are usually not sophisticated enough to provide specific and accurate information about potential health problems of the wearer. Kaunas University of Technology (KTU) researchers are developing a smart wrist-worn device for monitoring of atrial fibrillation -- a condition, which if left untreated can lead to serious health complications and even death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 26, 2019 Category: International Medicine & Public Health Source Type: news

Catheter for AF Maps, Ablates, and Sees Inside the Heart Catheter for AF Maps, Ablates, and Sees Inside the Heart
A balloon catheter in development to treat atrial fibrillation incorporates ablation, mapping, and visualization inside the heart. An early study shows excellent rates of ablation and procedure time.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 25, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Comparing treatments for atrial fibrillation
A study comparing a surgical procedure called catheter ablation with medications for atrial fibrillation will help inform treatment decisions. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - March 25, 2019 Category: Consumer Health News Source Type: news

Omron wins FDA nod for combined blood pressure monitor, EKG
Omron Healthcare (TYO:6645) has won FDA 510(k) clearance for its Blood Pressure Monitor + Echocardiogram device, according to a recently posted FDA release. The device, which was developed in collaboration with AliveCor, allows users to monitor both high blood pressure and atrial fibrillation, which the company said are critical risk factors for stroke. The newly cleared device is designed to sync with the Omron Connect mobile application to store, track and share heart health data with physicians to improve outcomes, the company said in its original product release. The combined product, under the moniker BP7900, was...
Source: Mass Device - March 25, 2019 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance AliveCor Omron Source Type: news

CardioFocus wins CE Mark for HeartLight X3 endoscopic ablation system
CardioFocus said today that it won CE Mark approval in the European Union for its HeartLight X3 endoscopic ablation system. The Marlborough, Mass.-based company said that the HeartLight X3 is its third-generation endoscopic ablation system intended to perform pulmonary vein isolation procedures using laser energy to block the abnormal electrical pathways that cause atrial fibrillation. The newly cleared HeartLight X3 uses direct tissue visualization, titratable laser energy and compliant balloon technology alongside a motor control system to allow for high-speed, circumferential lesion creation, CardioFocus said. Appr...
Source: Mass Device - March 25, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Regulatory/Compliance Cardiofocus Source Type: news

Eggs and Heart Disease; ADHD and Psychosis: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include best medicines for atrial fibrillation when a stent is used, an envelope for cardiac devices to reduce infection risk, psychosis and ADHD medicines, and eggs and cardiovascular disease (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 23, 2019 Category: Cardiology Source Type: news

A Sobering Breakthrough in AF Care A Sobering Breakthrough in AF Care
Frequent alcohol drinkers with atrial fibrillation benefitted from abstinence in a novel randomized trial, which prompts the question: Should temperance be prescribed before meds and procedures?theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 21, 2019 Category: Cardiology Tags: Cardiology Expert Column Source Type: news

RACE 7 ACWAS: Delayed Cardioversion Effective for Recent-Onset AF RACE 7 ACWAS: Delayed Cardioversion Effective for Recent-Onset AF
Delaying cardioversion is as safe and effective as acute cardioversion for recent-onset atrial fibrillation, a randomized trial shows. Many cases revert to sinus rhythm without cardioversion.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 20, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
WEDNESDAY, March 20, 2019 -- For patients with atrial fibrillation (AF), catheter ablation does not significantly reduce the risk for death, disabling stroke, serious bleeding, or cardiac arrest, but it does improve quality of life versus medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 20, 2019 Category: Pharmaceuticals Source Type: news

Boston Scientific touts Luminize catheter study
Boston Scientific (NYSE:BSX) this week touted results from a study of a single-shot ablation catheter for atrial fibrillation at a European cardiac rhythm conference. The Marlborough, Mass.-based medical device giant said the 100-patient AF-ficient I study of intermittent AF proceeded in two stages. Phase one, testing the original Luminize design, showed a pulmonary vein isolation rate of 88.9%; phase two, testing enhanced steering and electrodes, showed a PV isolation rate of 99.4%. The median balloon dwell time dropped from 92 minutes in the first phase to 29 minutes in the second, bringing total procedure time down...
Source: Mass Device - March 19, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Catheters Clinical Trials Featured Boston Scientific Cardiac Rhythm Management Source Type: news

Getting to the Core of the Apple Heart Study Getting to the Core of the Apple Heart Study
The co-principal investigator of a study that assessed the ability of an Apple Watch app to detect atrial fibrillation discusses the findings with John Mandrola, MD.theheart.org on Medscape (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - March 19, 2019 Category: Radiology Tags: Cardiology Commentary Source Type: news

Study shows catheter ablation for Afib significantly boosts quality of life
Patients who had catheter ablation for atrial fibrillation (Afib) had fewer symptoms, a significant long-term improvement in quality of life and fewer recurrences and hospitalizations than those who received drug therapy alone, according to a government-funded study. The same study showed that catheter ablation appeared no more effective than drugs in preventing strokes, deaths, and other complications. Get the full story on our sister site, Medical Design & Outsourcing. The post Study shows catheter ablation for Afib significantly boosts quality of life appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 19, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Catheters Clinical Trials News Well Mayo Clinic National Institutes of Health (NIH) Source Type: news

Apple Heart Study results: Notifications are rare, but often coincide with ECG-confirmed a-fib
Among more than 400,000 participants who enrolled in the study, only 0.5 percent ever received an atrial fibrillation alert from the app. (Source: mobihealthnews)
Source: mobihealthnews - March 18, 2019 Category: Information Technology Source Type: news

ACC 2019: Medtronic, Edwards low-risk TAVR trial data could pave way to new indications
Results from trials of both Medtronic‘s (NYSE:MDT) and Edwards Lifesciences‘ (NYSE:EW) transcatheter aortic valve replacement systems exploring their use in low-risk patients indicated that the devices were as safe as open surgery, paving the way for possible new indications for TAVR technology. Data from the trials were presented over the weekend at the American College of Cardiology 68th Annual Scientific Session 2019 in New Orleans and simultaneously published in the New England Journal of Medicine. Currently, TAVR devices are only approved by the FDA for treating severe aortic valve stenosis in patients at ...
Source: Mass Device - March 18, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Featured Replacement Heart Valves Edwards Lifesciences Medtronic Source Type: news

Apple ’s Watch Shows It Has ‘Heart’ in New Study
New light is being shed on the effectiveness of wearable technology to detect atrial fibrillation (Afib) thanks to preliminary results from a new study by Stanford University School of Medicine researchers and Apple. The Apple Heart Study was launched in November 2017 with more than 40,000 participants to determine whether a mobile app that uses data from a heart-rate pulse sensor the Apple Watch can identify Afib. For the study, each participant was required to have an Apple Watch (series 1, 2 or 3) and an iPhone. The most recent Apple Watch, which features a built-in ECG, wasn’t part of the study, as it...
Source: MDDI - March 18, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

XARELTO ® (rivaroxaban) Significantly Reduced the Risk of Overall Strokes and the Most Severe Strokes and Was Associated with Fewer Stroke-Related Deaths in the Real World Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation
(Source: Johnson and Johnson)
Source: Johnson and Johnson - March 18, 2019 Category: Pharmaceuticals Source Type: news

Your Apple Watch Might Help Spot a Dangerous Irregular Heartbeat
MONDAY, March 18, 2019 -- Someday soon, devices like the Apple Watch might be monitoring wearers for heart conditions such as potentially dangerous atrial fibrillation, a new study suggests. Atrial fibrillation, or " a-fib, " is a common form of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 18, 2019 Category: General Medicine Source Type: news